Related Experiment Video
Updated: Jul 28, 2025
Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
A systems and computational biology perspective on advancing CAR therapy
Vardges Tserunyan1, Stacey D Finley2
1Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA.
Abstract:
In the recent decades, chimeric antigen receptor (CAR) therapy signaled a new revolutionary approach to cancer treatment. This method seeks to engineer immune cells expressing an artificially designed receptor, which would endue those cells with the ability to recognize and eliminate tumor cells. While some CAR therapies received FDA approval and others are subject to clinical trials, many aspects of their workings remain elusive. Techniques of systems and computational biology have been frequently employed to explain the operating principles of CAR therapy and suggest further design improvements. In this review, we sought to provide a comprehensive account of those efforts. Specifically, we discuss various computational models of CAR therapy ranging in scale from organismal to molecular. Then, we describe the molecular and functional properties of costimulatory domains frequently incorporated in CAR structure. Finally, we describe the signaling cascades by which those costimulatory domains elicit cellular response against the target. We hope that this comprehensive summary of computational and experimental studies will further motivate the use of systems approaches in advancing CAR therapy.
Insights
Chimeric antigen receptor (CAR) therapy revolutionizes cancer treatment by engineering immune cells. Computational biology models are crucial for understanding CAR mechanisms and improving future cancer therapies.
Area of Science:
- Immunology
- Computational Biology
- Oncology
Background:
- Chimeric antigen receptor (CAR) therapy represents a significant advancement in cancer treatment, engineering immune cells to target tumors.
- Despite FDA approvals and ongoing clinical trials, the precise mechanisms of CAR therapy are not fully understood.
Purpose of the Study:
- To provide a comprehensive review of systems and computational biology approaches applied to CAR therapy.
- To elucidate the operating principles of CAR therapy and guide future design improvements.
Main Methods:
- Discussion of various computational models of CAR therapy, spanning from organismal to molecular scales.
- Description of the molecular and functional characteristics of costimulatory domains used in CAR constructs.
- Explanation of the signaling pathways activated by costimulatory domains leading to cellular anti-tumor responses.
Main Results:
- Identification of diverse computational modeling strategies for CAR therapy analysis.
- Detailed characterization of key costimulatory domains and their roles in CAR function.
- Elucidation of signaling cascades essential for CAR-mediated immune responses against cancer cells.
Conclusions:
- Systems and computational biology are vital for advancing CAR therapy research and development.
- A comprehensive understanding of CAR mechanisms can accelerate the design of more effective cancer treatments.
- This review encourages further integration of systems approaches to optimize CAR therapy.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...